Vascular Biology and Metabolism (VAM)

Overview

The VAM area was created to allow a comprehensive, cooperative and multidisciplinary approach in basic, clinical and epidemiology research. The ultimate goal is the innovation and transfer of solutions in a group of diseases that are closely interrelated and that constitute the leading cause of morbidity and mortality in the world: cardio-cerebrovascular disease, diabetes-metabolic syndrome and renal impairment. The VAM area includes preclinical and clinical research staff from our center, and collaborative work with groups of the highest international prestige. VAM area includes 8 groups: Cardiovascular Pathology, Diabetes and Metabolism, Nephrology, Ophthalmology (focused on retinal vascular disease), CIBBIM-Nanomedicine and Kidney Physiopathology, Medical Molecular Imaging, Neurovascular Diseases, and Research on Aging, Frailty and Transitions in Barcelona. All groups use an integrative tridimensional approach to generate knowledge on the mechanisms of diseases to generate new diagnostic and therapeutic tools.

Publications

248

total

1470

impact factor

5.93

average impact factor

Group Leader: Inzitari, Marco. PhD, MD

team

group-zoom

zoom

group-download

download

During 2019, the group has focused on ongoing projects, DIALCAT (RIS3Cat, funded by FEDER via ACCIÓ), an observational and intervention study on the relationship within diabetes and Alzheimer’s disease and IMAGINE (Marató TV3), a RCT on motivational interviewing to improve stroke patients’ adherence to rehabilitation. The international publications have been 12. The group has also obtained new competitive funding for the projects: 1) Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia-RECOGNISED Project (H2020); 2) Pre-FRONTal brain STability, key for action against disability in AGing: The FRONT STAGE Project (PIS-AES Carlos III); 3) +AGIL: integrated care for frail older adults in the community (BCN Ciència); and 4) PeRsonalitzant l’abordatge del pacient Oncològic Fràgil mitjançant l’avaluació i InTervenció individualitzada-PROFIT Project (Societat Catalano-balear de Cures Pal·liatives).

7

total

22

impact factor

3^.12

average impact factor

SELECTED ARTICLES

Pérez LM, Enfedaque-Montes MB, Cesari M, Soto-Bagaria L, Gual N, Burbano MP, Tarazona-Santabalbina FJ, Casas RM, Díaz F, Martín E, Gómez A, Orfila F, Inzitari M. A
Community Program of Integrated Care for Frail Older Adults: +AGIL Barcelona.
J Nutr Health Aging. 2019;23(8):710-716.
doi: 10.1007/s12603-019-1244-4.
IF: 2.66
Sansano-Nadal O, Giné-Garriga M, Brach JS, Wert DM, Jerez-Roig J, Guerra-Balic M, Oviedo G, Fortuño J, Gómara-Toldrà N, Soto-Bagaria L, Pérez LM, Inzitari M, Solà I, Martin-Borràs C, Roqué M.
Exercise-Based Interventions to Enhance Long-Term Sustainability of Physical Activity in Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Int J Environ Res Public Health. 2019 Jul 15;16(14). pii: E2527.
doi: 10.3390/ijerph16142527.
IF: 2.46
Inzitari M, Metti A, Rosano C, Udina C, Pérez LM, Carrizo G, Verghese J, Newman AB, Studenski S, Rosso AL.
Qualitative neurological gait abnormalities, cardiovascular risk factors and functional status in older community-dwellers without neurological diseases: The Healthy Brain Project.
Exp Gerontol. 2019 Sep;124:110652.
doi: 10.1016/j.exger.2019.110652.
IF: 3.08
Pérez LM, Hooshmand B, Mangialasche F, Mecocci P, Smith AD, Refsum H, Inzitari M, Fratiglioni L, Rizzuto D, Calderón-Larrañaga A.
Glutathione Serum Levels and Rate of Multimorbidity Development in Older Adults.
The Journals of Gerontology: Series A. 2019 Apr 25. pii: glz101.
doi: 10.1093/gerona/glz101.
IF: 4.711
Cancio JM, Vela E, Santaeugènia S, Clèries M, Inzitari M, Ruiz D.
Long-term Impact of Hip Fracture on the Use of Healthcare Resources: a Population-Based Study.
J Am Med Dir Assoc. 2019 Apr;20(4):456-461.
doi: 10.1016/j.jamda.2018.08.005. Epub 2018 Oct 1.
IF: 5.325

View all publications